Serum lipid levels and post-surgical risk for prostate cancer recurrence

According to an article published today in Cancer Epidemiology, Biomarkers and Prevention, men with dyslipidemia (an abnormal lipid profile) and elevated total cholesterol levels who have surgery for prostate cancer are at significantly increased risk for prostate cancer recurrence. … READ MORE …

Elevated cholesterol levels and risk for high-grade prostate cancer

A new report from a Scottish research team offers evidence that high plasma cholesterol levels are associated with an increased risk for a diagnosis of high-grade prostate cancer. … READ MORE …

The proposed REALITY trial and the impact of statins on prostate cancer

As a mentioned earlier this week, a new article by Moyad and Klotz has suggested that it may be possible to carry out a randomized clinical trial to evaluate the impact of statin therapy on the progression of early stage prostate cancer. … READ MORE …

Does taking a statin lower PSA in men being tested for prostate cancer risk?

Ever since it was recognized that there might be an association between taking statins (as a preventive treatment for elevated cholesterol levels) and risk for prostate cancer (which is now disputed), there has been an associated question as to whether men taking statins generally had a lower PSA level than men who were not, and what that might mean. … READ MORE …

Cholesterol sulfate as a potential marker for prostate cancer

In a somewhat surprising series of studies, a team of researchers at Purdue University and the Indiana University School of Medicine have demonstrated that cholesterol sulfate has high potential as a marker for prostate cancer. … READ MORE …

The Tuesday news reports: February 24, 2009

We have dealt separately with an article on the way in which surgical technique appears to affect the likelihood of positive surgical margins after robot-assisted laparoscopic prostatectomy (RALP). Other reports today cover:

  • Whether multifocal tumors are “riskier” that single prostate cancer tumors
  • The role of n-3 fatty acids in prevention of selected cancers (including prostate cancer)
  • Lycopene in prevention and treatment of prostate cancer
  • Serum cholesterol levels and prostate cancer
  • Different forms of imaging for prostate cancer localization during EBRT
  • Carboplatin + etopside chemotherapy in late-stage metastatic disease … READ MORE …